President Donald Trump announced Tuesday that the U.S. government will buy 100 million doses of Moderna’s experimental coronavirus vaccine, which is currently in late-stage human trials.
Moderna The deal for its mRNA-1273 vaccine is valued at $ 1.525 billion and will allow the federal government to purchase up to 400 million additional doses. The US has already invested $ 955 million in the development of Moderna’s vaccine, for a total investment of $ 2.48 billion, the company said in a press release on Tuesday.
The U.S. government’s deal with Moderna follows similar agreements it has made with pharmaceutical giants Pfizer and Johnson and Johnson about their potential Covid-19 vaccines.
“We’re investing in designing and manufacturing the top six vaccine candidates to ensure fast delivery. The military is ready to go, they are ready to ship a vaccine to Americans once one is fully FDA cleared and we ‘ll be I am very close to this approval, “said Trump during a press conference in the White House.
The US Department of Health previously announced that it would pay Pfizer and the biotech company BioNTech $ 1.95 billion to manufacture and ship 100 million doses of their Covid-19 vaccine with the option to purchase an additional 500 million doses. HHS later announced that it would give Johnson & Johnson more than $ 1 billion for 100 million cans with an option for an additional 200 million.
The deals are part of an effort by the Trump administration to accelerate the development, manufacture and distribution of vaccines and treatments to fight the coronavirus under the Operation Warp Speed program.
“We appreciate the US government’s trust in our mRNA vaccine platform and their continued support,” said Stephane Bancel, CEO of Moderna, in a press release.
This is a developing story. Please try again later.